
King’s Health Partners Clinical Trials Office Supports Takeda Clinical Trial to Recruit First Participant Globally
23 September 2026
We've received your request and look forward to sharing news about King's Health Partners Clinical Trials Office with you soon. For our latest updates, you can also follow us on LinkedIn.
If you'd like to get in touch with the team you can contact us.


In conversation with Professor Anil Dhawan
Prof Dhawan is a Consultant in Paediatric Hepatology with a special interest in liver cell transplantation, immuno-suppression after liver transplantation, Wilson’s Disease, neonatal cholestasis and acute liver failure. Prof Dhawan is a well known internationally and has held or currently holds board level appointments with the European Society of Paediatric Gastroenterology, Hepatology and Nutrition, International Liver Transplantation Society and Cell Transplantation Society. Prof Dhawan qualified as a doctor in India and has since held appointments in the USA and the UK. He is also the Clinical Academic Group (CAG) Leader for Child Health at King’s Health Partner
26 August 2026

In conversation with Professor James MacCabe
Professor James MacCabe is a Consultant Psychiatrist and Clinical Academic based at South London and Maudsley NHS Foundation Trust, Europe’s largest mental health research centre. As an experienced King’s Health Partners (KHP) Chief Investigator on both commercially sponsored and non-commercial studies, he works closely with the KHP Clinical Trials Office (KHPCTO) to deliver complex trials in psychosis across diverse, real-world populations.
15 July 2026

In conversation with Dr Andrew Pink
Dr Andrew Pink has spent more than a decade leading Phase II–IV studies that bring emerging treatments for conditions such as eczema, psoriasis, and prurigo nodularis directly into NHS care.

New website elevates work of King's Health Partners Clinical Trials Office